0 CHECKOUT

PRODUCT FILTERS

REGION

37
11
7
7
5

COUNTRY

11
3
2
1
1

CATEGORIES

  • 20
  • 16
  • 16
  • 13
  • 11
  • 11
  • 9
  • 7
  • 7
  • 6
  • 6
  • 5
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

38
58
64
115

PUBLISHED

2
16
28
115

PRODUCT TYPE

58
33
18
2
2
1
1

Search for: "Clinical Management of Ovarian Cancer"

Frontier Pharma: Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation

Ovarian cancer is the sixth most common cancer in females and it also has the highest mortality rate of gynecological cancers. The five-year survival rate is approximately 45%, although the disease...

Published:  December 2015
Price:  From

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

Published:  January 2016
Price:  From

Oncology Drug Report - 2014

Report for the first time identifies and profiles 931 Active Cancer Drug Development companies from 33 countries worldwide, developing 2237 cancer-targeting drugs It evaluates 19 major cancer indications...

Published:  May 2014
Price:  From

Oncology Intelligence: A Comprehensive Report for Decision Making

Oncology Intelligence Report 2013 provides complete landscape on cancer drug development, by bringing more authentic data under evaluation and is designed in a manner to keep knowledge instant, clear...

Published:  January 2013
Price: 

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

Published:  January 2016
Price:  From

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

Published:  January 2016
Price:  From

Current Approaches to Endometrial Cancer

As the symptom of atypical genital bleeding and discharge appears early in the clinical course, many women with endometrial cancer have early-stage disease at diagnosis. This leads to general recognition...

Published:  November 2014
Price: 

The Top 70 Western European Oncology Contract Research Organisations

It is estimated that clinical development expenditures outsourced by pharmaceutical, medical device and biotechnology companies worldwide in 2012 was approximately Euro 20 6 billion With greatly developed...

Published:  July 2013
Price:  From

Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug Development

GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers...

Published:  December 2011
Price:  From

Soricimed Biopharma Inc. - Product Pipeline Analysis, 2014 Update

Summary Soricimed Biopharma Inc. (Soricimed), formerly BioProspecting NB Inc. is a drug development company. The company carries out the development and commercialization of therapeutic and diagnostic...

Published:  June 2014
Price:  From

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

Published:  January 2016
Price:  From

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

Published:  January 2016
Price:  From

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

Published:  July 2014
Price:  From

DNA Sequencing - Technologies, Markets and Companies

This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing...

Published:  January 2016
Price:  From

Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends and Pipeline Analysis)

“GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline...

Published:  May 2014
Price:  From

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular...

Published:  May 2013
Price:  From

Antibody Drug Conjugates Market (3rd Edition)

The “Antibody Drug Conjugates Market (3rd edition), 2015-2025” report provides a comprehensive analysis of the current market landscape and future outlook of the growing pipeline of ADCs. The ADC market...

Published:  December 2015
Price:  From

Clinical Laboratory Services - Global Strategic Business Report

This report analyzes the worldwide markets for Clinical Laboratory Services in US$ Million by the following Product Segments: Hospital-Based Laboratories, and Others The report provides separate comprehensive...

Published:  January 2014
Price:  From

Novel cancer-related biomarkers Volume 2

Aims and Scope Various KLK proteins and their encoding genes have attracted increased attention among scientists and clinicians worldwide since they represent very interesting and functionally distinct...

Published:  December 2012
Price:  From

Cancer Diagnostic Testing World Markets

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans...

Published:  January 2016
Price:  From
Loading Indicator

Our Clients

  • Ikea Systems B.V.
  • GlaxoSmithKline PLC
  • BT Group PLC.
  • Philips N.V.
  • BSH Home Appliances Ltd
  • Foreign & Commonwealth Office